The Role Of Genetic Factors In Adult ADHD
Posted on: Friday, 10 July 2009, 12:05 CDT
22nd Congress of the European College of Neuropsychopharmacology (ECNP), 12 - 16 September 2009, Istanbul, TurkeyDr. Barbara Franke, who is coordinating the International Multicentre persistent ADHD CollaboraTion (IMpACT) will present the latest findings in the identification of risk genes for ADHD. She will explain how the findings of IMpACT may help to define targets for the development of new and more effective treatments for ADHD, and also contribute to early disease prevention.
Attention deficit/hyperactivity disorder, or ADHD, is one of the most common neuropsychiatric disorders of childhood. Worldwide, 3–12% of children are affected with the disorder, whose symptoms include age-inappropriate hyperactive and impulsive behavior and/or a reduced ability to focus attention . ADHD has classically been viewed as a disorder of children, but the majority of patients carries ADHD symptoms, or even the full ADHD-diagnosis, into adulthood. This leads to social and professional problems and is associated with considerable costs.
Converging evidence suggests that ADHD aetiology has a robust genetic component. The heritability of the adult form of ADHD appears even higher than that of children. With the adult form of ADHD being the most severe one, focusing on the genetics of ADHD in adults can be expected to guide future research in this challenging field. For that reason, a group of researchers focusing on the genetics of adult ADHD decided to pool their efforts in the International Multicentre persistent ADHD CollaboraTion (IMpACT), investigating the largest clinical ADHD sample worldwide. Dr. Barbara Franke, Ph.D., who is coordinating this promising research project, will present the latest findings in the identification of risk genes for ADHD. She will explain how the findings of IMpACT may help to define targets for the development of new and more effective treatments for ADHD, and also contribute to early disease prevention.
--------------
On The Net:
AlphaGalileo
Related Articles
- Acetaminophen May Be Linked To Asthma In Children And Adults
- Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration
- Video: New Biological Therapy Ilaris(R) Approved in US to Treat Children and Adults with CAPS, a Serious Life-Long Auto-Inflammatory Disease
- VYVANSE(R) (Lisdexamfetamine Dimesylate) Now Available in U.S. Pharmacies Nationwide in Six Dosage Strengths, Allowing Physicians to Titrate to Achieve Optimal Efficacy and Tolerability in Children and Adults With ADHD
- FDA Approves CONCERTA(R) (Methylphenidate HCI) Extended-Release Tablets for Treatment of ADHD (Attention Deficit Hyperactivity Disorder) in Adults
- New Study: Pine Bark Extract Reduces ADHD Symptoms in Children
- Vitamin D Deficiency Leaves Millions of Children and Adults at Risk For Numerous Diseases and Disorders
- Focalin XR(TM) Clinical Studies Suggest Investigational Once-Daily ADHD Treatment is Safe and Effective in Both Children and Adults
- New Studies Suggest Investigational Once-Daily ADHD Treatment Is Safe and Effective in Both Children and Adults
- More Children Getting Adult Diabetes
Rating: 3.3 / 5 (6 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds